Presentation TCT 2013 The Amaranth PLLA-based BRS (with and without Sirolimus Elution): Design, Experimental and FIH Results Presenter: Juan Granada October 27, 2013
Presentation TCT 2013 New Insights into the Risks of Post-CABG Stroke Presenter: Tullio Palmerini October 27, 2013
Presentation TCT 2013 iFR: Background, Physiologic Rationale for Basal Indices, and Clinical Data Presenter: Justin Davies October 31, 2013
Presentation TCT 2013 Cases III and IV: Left Main and Bifurcation Lesions Presenter: Bon-Kwon Koo October 31, 2013
Presentation TCT 2013 How To Use Your NCDR Data to Benefit Your Lab and Your Patients Presenter: Ralph Brindis October 31, 2013
Presentation TCT 2013 Nanomedicine: From Drug Delivery to Nanobots Presenter: Samuel Wickline October 28, 2013
Presentation TCT 2013 Case Presentation 2: A Totally Occluded In-Stent CTO Presenter: Lei Ge October 31, 2013
Presentation TCT 2013 A Surgeon Is the Best Person to Determine Risk Assessment for TAVR! Presenter: A. Pieter Kappetein October 31, 2013
Presentation TCT 2013 The Evolution of Metallic DES: Are Patient Outcomes Improving? Presenter: Stephan Windecker October 31, 2013
Presentation TCT 2013 DESolve Nx Novolimus-Eluting PLLA-Based BRS: First Report of the 6-month OCT and 12-month Clinical and Imaging Results Presenter: Stefan Verheye October 27, 2013